Avalon GloboCare Prices $9.75M At-The-Market Private Placement Under Nasdaq Rules

Reuters
Feb 27
<a href="https://laohu8.com/S/ALBT">Avalon GloboCare</a> Prices $9.75M At-The-Market Private Placement Under Nasdaq Rules

Avalon GloboCare Corp. said it entered definitive agreements for a private placement priced at-the-market under Nasdaq rules, selling 6,372,550 shares of common stock or pre-funded warrants, along with Series A-1 and Series A-2 warrants to purchase up to an additional 12,745,100 shares. The securities were offered to accredited investors in an unregistered offering under Section 4(a)(2) and Regulation D at $0.51 per share, with expected gross proceeds of about $3.25 million and up to roughly $6.5 million more if the warrants are fully exercised. H.C. Wainwright & Co. is acting as exclusive placement agent, and the company said it plans to use net proceeds to repay certain debt and for working capital and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalon Globocare Corp. published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10